Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

Ligase Targeting Drug Development Summit - May 2021 - Digital Event

Evvnt Promotion / evvnt
Archivio
-
25.05.2021 - 27.05.2021  Online
Time: 08:30 - 17:00
 
Temi della conferenza
As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Chris De Savi Vice President Head of Drug Discovery Kymera, Miklos Bekes Senior Research Investigator and Group Leader in Platform Biology Arvinas, Daniel Nomura Professor of Chemistry, University of California Berkeley and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/717315-2?pid=4832
Mr. Customer Service
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference Only: USD 1999.0, Conference + 1 Workshop: USD 2348.0, Conference + 2 Workshops: USD 2697.0
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzÄrzte der WeltAMREF - African Medical and Research FoundationAlumni Club Medizinische Universität WiennewTreeEuropean Health Forum GasteinSwiss Tropical and Public Health Institute